BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parrish NF, Feurer ID, Matsuoka LK, Rega SA, Perri R, Alexopoulos SP. The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes. Transplant Direct 2019;5:e427. [PMID: 30882032 DOI: 10.1097/TXD.0000000000000866] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Karunungan KL, Sanaiha Y, Hernandez RA, Wilhalme H, Rudasill S, Hadaya J, DiNorcia J, Benharash P. Impact of Payer Status on Delisting Among Liver Transplant Candidates in the United States. Liver Transpl 2021;27:200-8. [PMID: 33185336 DOI: 10.1002/lt.25936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Manka P, Syn WK. NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease. Dig Dis Sci 2021;66:2147-8. [PMID: 32979160 DOI: 10.1007/s10620-020-06620-9] [Reference Citation Analysis]
3 Tincopa MA, Weinberg RL, Sengupta S, Slivnick J, Corbett J, Sonnenday CJ, Fontana RJ, Sharma P. The Utility of Noninvasive PET/CT Myocardial Perfusion Imaging in Adult Liver Transplant Candidates. Transplantation Direct 2022;8:e1311. [DOI: 10.1097/txd.0000000000001311] [Reference Citation Analysis]
4 Welch N, Attaway A, Bellar A, Alkhafaji H, Vural A, Dasarathy S. Compound Sarcopenia in Hospitalized Patients with Cirrhosis Worsens Outcomes with Increasing Age. Nutrients 2021;13:659. [PMID: 33670535 DOI: 10.3390/nu13020659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Castellana M, Donghia R, Guerra V, Procino F, Lampignano L, Castellana F, Zupo R, Sardone R, De Pergola G, Romanelli F, Trimboli P, Giannelli G. Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis. J Clin Med 2021;10:1877. [PMID: 33925992 DOI: 10.3390/jcm10091877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Molinari M, Fernandez-Carrillo C, Dai D, Dana J, Clemente-Sanchez A, Dharmayan S, Kaltenmeier C, Liu H, Behari J, Rachakonda V, Ganesh S, Hughes C, Tevar A, Al Harakeh H, Emmanuel B, Humar A, Bataller R. Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. Transpl Int 2021;34:1105-22. [PMID: 33780554 DOI: 10.1111/tri.13873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hughes CB, Humar A. Liver transplantation: current and future. Abdom Radiol (NY) 2021;46:2-8. [PMID: 31953588 DOI: 10.1007/s00261-019-02357-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
8 Paik JM, Golabi P, Biswas R, Alqahtani S, Venkatesan C, Younossi ZM. Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States. Hepatol Commun 2020;4:890-903. [PMID: 32490324 DOI: 10.1002/hep4.1510] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
9 Castellana M, Donghia R, Lampignano L, Castellana F, Zupo R, Sardone R, Pergola G, Giannelli G. Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma. J Clin Med 2021;10:4638. [PMID: 34682759 DOI: 10.3390/jcm10204638] [Reference Citation Analysis]